With the help of the Blavatnik Biomedical Accelerator, innovators like Chenghua Gu and David Sinclair are advancing their research with an eye on commercial partnership.
- October 03, 2014
The Blavatnik Fellowship in Life Science Entrepreneurship kicked-off a second exciting year with reception to welcome the new fellows.
- September 16, 2014
Professors Dan Finley and Randy King are poised to change the future for those who suffer from neurodegenerative diseases. With the help of OTD’s Biomedical Accelerator, they were able to build on this foundation and advance the frontiers of science and healthcare.
- May 07, 2014
As drug companies shift focus, academia ramps up its role in bringing discoveries to market. The Blavatnik Biomedical Accelerator has pioneered novel strategies for transitioning cutting-edge scientific innovation from the university to the commercial sphere. Read more about how Harvard is at the forefront of a growing trend to support translational research at universities.
- February 27, 2014
Advanced under license from Harvard and funded by the Blavatnik Biomedical Accelerator, Proteostasis seeks to develop therapeutic candidates based on the Usp14 technology of Harvard Medical School.
Page 3 of 4